Sanofi Reaches New Milestone in Fight Against Malaria: 300 million ASAQ Treatments Delivered in Africa

Paris, France - April 25, 2014 - Sanofi (EURONEXT: SAN and NYSE: SNY) announced on

World Malaria Day that 300 million treatments of anti-malarial ASAQ Winthrop®

 have been delivered in Africa since the medication became available in 2007.

en.sanofi.com/Images/36202_20140425_MalariaDay_en.pdf

Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

Rickettsia Articles Received April 24, 2014.



Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

Streptococci Articles Received April 24, 2014.



Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

Parasites Articles Received April 24, 2014.



Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

HIV/Aids Articles Received April 24, 2014



Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA | Gilead

Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA | Gilead

Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

Received April 22, 2014.



Ahead of Print - Articles - Emerging Infectious Disease journal - CDC

Two million malaria treatments for children hit the ground in Zambia - YouTube

Two million malaria treatments for children hit the ground in Zambia - YouTube

February 2014 ACIP Meeting -- Welcome & Introductions - YouTube

Opening remarks for February 2014 The U.S. Advisory Committee of Immunization Practices meeting introduced by Dr. Larry Pickering and Dr. Jon Temte.



February 2014 ACIP Meeting -- Welcome & Introductions - YouTube

ACIP Influenza LAIV - YouTube

LAIV vs. IIV Comparative Safety Studies in Children, Safety of Live-Attenuated vs. Inactivated Influenza Vaccines for Healthy Children (GRADE), LAIV supply update, and Annual Influenza Recommendations.



ACIP Influenza LAIV - YouTube

Healthcare-Associated Infections in the United States - YouTube

A new CDC video depicts progress and challenges in combating healthcare-associated infections in the United States.



Healthcare-Associated Infections in the United States - YouTube

Responding to Outbreaks - YouTube

An outbreak of the Ebola virus hits in western Uganda and caused dozens of illnesses or deaths. In RESPONDING TO OUTBREAKS, a team of investigators from the CDC Special Pathogens Branch travels to Uganda. They work to bring the outbreak under control and learn more about the reservoir hosts for the Ebola and Marburg viruses.



Responding to Outbreaks - YouTube

USDA Blog » “Safety Datapalooza” Brings More Usability of FSIS Salmonella Data

USDA Blog » “Safety Datapalooza” Brings More Usability of FSIS Salmonella Data

Merck’s Investigational Chronic Hepatitis C Combination Therapy MK-5172/MK-8742 Demonstrates Antiviral Activity in Hard-to-Cure Patients with HCV Genotype 1 Infection | Merck Newsroom Home

Merck’s Investigational Chronic Hepatitis C Combination Therapy MK-5172/MK-8742 Demonstrates Antiviral Activity in Hard-to-Cure Patients with HCV Genotype 1 Infection | Merck Newsroom Home

Bristol-Myers Squibb Presents Phase III Data Demonstrating that Investigational All-oral Daclatasvir and Asunaprevir Therapy Achieved SVR12 Rates of up to 90% Among Broad Range of Genotype 1b Hepatitis C Patients | BMS Newsroom

Bristol-Myers Squibb Presents Phase III Data Demonstrating that Investigational All-oral Daclatasvir and Asunaprevir Therapy Achieved SVR12 Rates of up to 90% Among Broad Range of Genotype 1b Hepatitis C Patients | BMS Newsroom

Merck Announces Results from Studies Evaluating Investigational Hepatitis C Treatments, MK-5172 and MK-8742, in Treatment-Naïve Patients with Genotype 1 Infection | Merck Newsroom Home

Merck Announces Results from Studies Evaluating Investigational Hepatitis C Treatments, MK-5172 and MK-8742, in Treatment-Naïve Patients with Genotype 1 Infection | Merck Newsroom Home

USGS Release: Sea Otters Can Get the Flu, Too (4/8/2014 12:45:13 PM)

USGS Release: Sea Otters Can Get the Flu, Too (4/8/2014 12:45:13 PM)

Zika Fever in Cook Islands - Watch - Level 1, Practice Usual Precautions - Travel Health Notices | Travelers' Health | CDC

Zika Fever in Cook Islands - Watch - Level 1, Practice Usual Precautions - Travel Health Notices | Travelers' Health | CDC

Polio in Iraq - Alert - Level 2, Practice Enhanced Precautions - Travel Health Notices | Travelers' Health | CDC

Polio in Iraq - Alert - Level 2, Practice Enhanced Precautions - Travel Health Notices | Travelers' Health | CDC

Polio in Equatorial Guinea - Alert - Level 2, Practice Enhanced Precautions - Travel Health Notices | Travelers' Health | CDC

Polio in Equatorial Guinea - Alert - Level 2, Practice Enhanced Precautions - Travel Health Notices | Travelers' Health | CDC

Bristol-Myers Squibb Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C | BMS Newsroom

U.S. application submission marks third major daclatasvir regulatory milestone globally, follows E.U. and Japan



Bristol-Myers Squibb Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C | BMS Newsroom

Kleiner Biss, große Gefahr: Wenn ein "Vektor" krank macht | Wissen & Umwelt | DW.DE | 07.04.2014

Wenn es nach der Weltgesundheitsorganisation geht, sollte im 21. Jahrhundert niemand mehr am Biss einer Mücke oder Zecke sterben. Die WHO hat den sogenannten Vektorkrankheiten den Kampf angesagt.



Kleiner Biss, große Gefahr: Wenn ein "Vektor" krank macht | Wissen & Umwelt | DW.DE | 07.04.2014

CDC Press Release: Lassa Fever Reported in U.S. Traveler Returning from West Africa

CDC Press Release: Lassa Fever Reported in U.S. Traveler Returning from West Africa

MMWR News Synopsis for April 3, 2014

MMWR News Synopsis for April 3, 2014

New Tick-Born Virus Infecting Missourians

New Tick-Born Virus Infecting Missourians